OVERVIEW
Lusante is a research and development corporation dedicated to planning and producing premium oral supplements. The main objective of the company is to enhance men’s and women’s overall health with a particular focus on eye health. We thrive to provide an array of effective supplements, which are designed for specific ocular conditions. The ultimate goal is to maintain the health of ocular tissues struggling with environmental insults such as UV light and oxidative stress, as well as improving recovery from ocular disorders and minimize the associated complications and tissue destruction.
OVERVIEW
Lusante is a research and development corporation dedicated to planning and producing premium oral supplements. The main objective of the company is to enhance men’s and women’s overall health with a particular focus on eye health. We thrive to provide an array of effective supplements, which are designed for specific ocular conditions. The ultimate goal is to maintain the health of ocular tissues struggling with environmental insults such as UV light and oxidative stress, as well as improving recovery from ocular disorders and minimize the associated complications and tissue destruction.
Products
VisuMix M
VisuMix M is specific formulation designed for macular (yellow spot) health. VisuMix M is available on Amazon.
VisuMix V
VisuMix V is a specific formulation for retinal microvasculopathies (diabetic and hypertensive retinopathy).View VisuMix V on Amazon
EverLife IB
EverLife IB has a formulation as an immune booster. EverLife IB is under formulation. View EverLife IB on Amazon
EverLife MF
EverLife MF enhances mens’ health and fertilization. EverLife MF is under production. click bellow to view more
Products
VisuMix M
Visumix M is specifically developed to improve microvascular health in retinal vascular disorders such as diabetic retinopathy.
VisuMix V
VisuMix V (targeting retinal microvasculopathies) is under production. The release date of that would be in the autumn 2022.
EverLife IB
EverLife IB has a formulation as an immune booster. The approximate release date of EverLife IB would be in the winter 2022.
VisuMix R
VisuMix R (targeting post-LASIK eyes) is under formulation. The approximate release date of that would be in the spring 2023.
VisuMix G
VisuMix G (targeting glaucoma) is under formulation. The approximate release date of VisuMix G would be in the spring 2023.
EverLife MF
EverLife MF enhances mens’ health and fertilization. The approximate release date of that would be in the autumn 2022.
Latest News
Lusante company was initially established on February 4th, 2019 in Ontario, Canada. It is a research and development corporation dedicated to planning and producing premium oral supplements aiming at preventing a variety of health issues. Lusante Inc. launched its first product (VisuMix M) in October 2021. The company also have two supplements under production namely VisuMix V, and EverLife MF, and three other supplements under formulation including VisuMix R, VisuMix G, and EverLife IB
VisuMix M is a general formulation designed for overall ocular health. It contains all ingredients of AREDS II formula, which have been proved to halt age-related macular degeneration. The ingredients of VisuMix M also claimed to prevent cataracts and diabetic/hypertensive retinopathy.
VisuMix V is a specific formulation for retinal microvasculopathies (diabetic and hypertensive retinopathy). The approximate release date of VisuMix V would be in the autumn 2022.
VisuMix R targets post corneal refractive surgery conditions. The approximate release date of VisuMix R would be in the spring 2023.
VisuMix G targets retinal neurodegenerations, including glaucoma. The approximate release date of VisuMix G would be in the spring 2023.
EverLife IB has a formulation as an immune booster. The approximate release date of EverLife IB would be in the winter 2022.
EverLife MF enhances mens’ health and fertilization. The approximate release date of EverLife MF would be in the autumn 2022.
Age-related macular degeneration (ARMD) is the leading cause of irreversible vision loss in the aging population. Currently, there is no effective treatment for dry ARMD. Previous studies showed that some vitamins and minerals may prevent ARMD mainly via antioxidant effects.
Cataracts are the most common cause of reversible vision loss in the aging population. The vision could be effectively restored by cataract surgery. Current literature suggests that some vitamins and antioxidants may prevent the development of age-related cataracts.
Diabetic retinopathy is the leading cause of blindness in the working-age group. When occurred, the vision loss from diabetic retinopathy is hard to be restored. A healthy diet including essential vitamins might help prevent diabetes and its microvascular complications such as retinopathy.
Latest Articles
sudden vision loss in one or both eyes
All about Transient Vision Loss
Peripheral Vision Loss and Tunnel Vision
